查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018507

一次性內視鏡市場：2026-2032年全球市場預測，依產品、類型、應用、最終用戶及通路分類

Disposable Endoscopes Market by Product, Type, Application, End-User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，一次性內視鏡市場價值將達到 19.8 億美元，到 2026 年將成長至 22.5 億美元，到 2032 年將達到 52.7 億美元，複合年成長率為 14.95%。

主要市場統計數據
基準年 2025 19.8億美元
預計年份：2026年 22.5億美元
預測年份 2032 52.7億美元
複合年成長率 (%) 14.95%

簡要介紹一次性內視鏡的快速普及，以及感染控制、工作流程效率和臨床期望如何重新定義手術護理。

一次性內視鏡的出現，為手術治療帶來了關鍵性的轉捩點，這主要源自於對感染預防、工作流程效率和臨床醫師便利性這三者之間緊密相關的需求。一次性內視鏡挑戰了傳統的再處理模式，無需複雜的滅菌流程，從而降低了交叉感染的風險，並縮短了手術間的周轉時間。同時，技術的進步提高了影像品質、操作性和與數位平台的整合度，使一次性內視鏡成為越來越多臨床適應症的可行選擇。

技術成熟度、優先考慮感染預防、採購創新和永續性如何重塑部署模式和競爭定位。

一次性內視鏡產業正經歷一場變革，其意義遠不止於簡單地取代可重複使用設備。首先，技術的成熟提升了光學性能、人體工學設計和設備可靠性，提高了一次性內視鏡平台的臨床可靠性，使其能夠應用於更廣泛的手術操作。其次，供應鏈的創新和生產規模的擴大正逐步縮小一次性內視鏡與可重複使用系統之間的性價比差距，在某些特定應用情境下，採購決策也傾向於選擇一次性產品。第三，備受矚目的感染事件和公眾意識的提高，使得人們更加重視感染預防，更加關注設備間的交叉感染風險，從而推動了醫療機構對一次性內視鏡產品的需求。

評估新關稅措施對一次性內視鏡供應鏈經濟、籌資策略和區域製造決策的連鎖影響。

2025年實施的新關稅政策改變了進口零件、組裝和成品的相對貿易經濟性，給一次性內視鏡供應鏈帶來了巨大壓力。關鍵零件和成品進口關稅的提高增加了買家的總成本，並促使製造商重新評估其地理佈局、供應商合約和庫存策略。為此，各組織正在加快降低成本風險的步伐，包括供應商多元化、啟動近岸外包和區域製造夥伴關係以及重新談判長期合約。

詳細的細分洞察揭示了產品類別、設備類型、臨床應用、最終用戶特徵和分銷管道如何塑造差異化的商業化策略。

在一次性內視鏡領域，清晰的產品細分和臨床應用決定了創新重點和市場推廣路徑。按產品分類，支氣管鏡、大腸鏡和軟式內視鏡視鏡和硬式內視鏡之間的差異影響著設計權衡、成本結構以及對不同治療環境的適用性，因為臨床醫生會評估其操作性、可視性和觸覺回饋。按應用分類，關節鏡、支氣管鏡、耳鼻喉科內視鏡、胃腸內視鏡和泌尿系統內視鏡等多種應用，需要針對每個專科的複雜手術流程和診斷成像需求制定個性化的設備規格和臨床檢驗。

影響美洲、歐洲、中東和非洲以及亞太地區採購和商業化方法的關鍵區域趨勢，以及每個地區不同的採用路徑。

區域趨勢影響關鍵市場的採用速度和競爭策略，而影響策略的因素和限制因素因地區而異。在美洲，醫療保健系統正努力在滿足感染控制需求的同時，最佳化處理能力並應對成本削減的壓力，這促使醫療機構在風險較高或周轉率較高的手術領域選擇性地採用一次性產品。市場活動的特點是策略採購合約、試驗計畫以及對生命週期成本分析日益成長的關注。在歐洲、中東和非洲，由於法律規範、報銷結構和醫療服務模式的區域差異，市場狀況呈現多樣化的特徵。一些市場正在迅速採用一次性產品來解決污染問題，而另一些市場則採取更為謹慎的態度，等待成本效益的證據以及與環境政策的契合度。

製造商、新參與企業和分銷合作夥伴之間的競爭動態和策略行動，優先考慮臨床證據、規模和綜合服務交付。

一次性內視鏡市場的競爭格局日益取決於企業整合臨床可靠性、生產規模和服務導向商業計劃的能力。領先的製造商正加大對臨床試驗、可用性測試和上市後監測的投入，以支持其安全性和有效性聲明，同時擴大產能並增強供應鏈韌性，以滿足不斷變化的需求。醫療設備開發商與臨床機構之間的合作日益普遍，以此加速真實世界證據的累積和臨床醫生的認可；而與契約製造的合作則有助於實現更靈活的產能管理和成本最佳化。

為製造商和醫療保健系統提供實用策略指南，以協調臨床證據、供應彈性、定製商業模式和永續性舉措，從而促進其應用。

產業領導者應優先考慮多管齊下的策略，將產品創新與採購實際情況、臨床檢驗和永續性相結合。首先，投資於有針對性的臨床證據項目，以證明產品在特定應用場景下具有等效性或優越性，重點關注患者安全結果和營運指標，例如周轉時間和再處理負擔。其次，最佳化製造和採購策略，透過零件供應商多元化、探索區域製造夥伴關係關係以及建立靈活的契約製造籌資策略，降低關稅和供應鏈中斷帶來的風險。第三，發展差異化的商業模式，以滿足門診手術中心、診斷中心和醫院/診所的需求，並提供客製化的價格、服務套餐和培訓，以加速產品推廣應用。

為了確保實用見解和明確的局限性，我們採用了嚴格的混合方法研究方法，結合了關鍵相關人員的訪談、第二手資料的整合和迭代檢驗。

本分析的調查方法結合了質性一手研究、結構化二手研究和迭代檢驗，確保了研究的穩健性和相關性。一手數據來自對臨床醫生、採購經理、監管專家和供應鏈高階主管的深入訪談，從而深入觀點臨床績效標準、採購限制和營運重點。二手研究則利用監管出版刊物、臨床文獻、產業白皮書和公開的政策文件，取得醫療設備標準、感染預防指南和環境政策趨勢的背景資訊。

最終的綜合分析平衡了感染預防、營運效率、供應鏈權衡和永續性責任等方面的益處，從而指導策略決策。

一次性內視鏡代表著手術器械策略的關鍵轉折點，它在感染控制和工作流程效率方面帶來了切實的好處，同時也對成本結構、永續性和供應鏈設計提出了新的考量。隨著一次性使用平台臨床表現的不斷提升，其普及程度將取決於製造商能否充分證明其臨床價值、解決採購和定價方面的複雜性，以及展現可靠的環境管理能力。因此，醫療機構和門診服務提供者必須認真權衡感染控制方面的即時效益與長期總成本和環境責任之間的利弊，而循證試驗計畫和分階段實施則是一種審慎的做法。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：一次性內視鏡市場：依產品分類

  • 支氣管鏡檢查
  • 大腸鏡檢查
  • 十二指腸內視鏡檢查

第9章：一次性內視鏡市場：按類型分類

  • 軟式內視鏡
  • 硬式內視鏡

第10章：一次性內視鏡市場：依應用領域分類

  • 關節鏡
  • 支氣管鏡檢查
  • 耳鼻喉內視鏡檢查
  • 胃腸內視鏡檢查
  • 泌尿系統視鏡檢查

第11章：一次性內視鏡市場：依最終用戶分類

  • 門診手術中心
  • 診斷中心
  • 醫院和診所

第12章：一次性內視鏡市場：依通路分類

  • 直銷
  • 線上

第13章：一次性內視鏡市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：一次性內視鏡市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：一次性內視鏡市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國一次性內視鏡市場

第17章：中國一次性內視鏡市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3NT Medical, Inc.
  • Altek Corporation
  • Ambu A/S
  • B. Braun Melsungen AG
  • BioVision Technologies, LLC by ATL Technology, LLC
  • Boston Scientific Corporation
  • Daichuan Medical（Shenzhen）Co., Ltd
  • Dyne Medical Group
  • EnlightenVue, Inc.
  • Flexicare Medical Limited
  • Fujifilm Holdings Corporation
  • Hill-Rom Holdings, Inc.
  • Integrated Endoscopy
  • Intersurgical Ltd.
  • IQ Endoscopes Limited
  • J-Sol Medical Co., Ltd.
  • Karl Storz SE & Co. KG
  • NeoScope, Inc.
  • Olympus Corporation
  • OTU Medical Inc.
  • Parburch Medical Developments Ltd
  • PENTAX Medical
  • Scivita Medical Technology Co., Ltd.
  • STERIS Corporation
  • Teleflex Incorporated
  • The Cooper Companies, Inc.
  • The Surgical Company
  • Verathon Inc. by Roper Technologies, Inc.
  • Zhejiang Geyi Medical Instrument Co., Ltd.
  • Zsquare Ltd.
Product Code: MRR-A339DAEFA6BA

The Disposable Endoscopes Market was valued at USD 1.98 billion in 2025 and is projected to grow to USD 2.25 billion in 2026, with a CAGR of 14.95%, reaching USD 5.27 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.98 billion
Estimated Year [2026] USD 2.25 billion
Forecast Year [2032] USD 5.27 billion
CAGR (%) 14.95%

A concise introduction to the disruptive rise of single-use endoscopes and how infection control, workflow efficiency, and clinical expectations converge to redefine procedural care

The emergence of disposable endoscopes has introduced a pivotal inflection point in procedural care, driven by converging imperatives around infection prevention, workflow efficiency, and clinician convenience. Single-use endoscopes challenge traditional reprocessing paradigms by eliminating the need for complex sterilization cycles, thereby reducing cross-contamination risk and shortening turnaround times between procedures. In parallel, technological advances have improved image quality, maneuverability, and integration with digital platforms, making disposables a viable alternative for a growing set of clinical indications.

Adoption is being shaped by an evolving interplay among hospital administrators, procurement teams, and clinicians who must weigh per-procedure costs against operational savings and patient safety gains. At the same time, payers and health systems are scrutinizing total cost of care implications, while regulatory agencies refine expectations for product performance and post-market surveillance. Consequently, manufacturers, distributors, and health systems are all recalibrating strategies to address procurement complexity, clinician acceptance, and lifecycle sustainability, establishing a new competitive dynamic in endoscopy.

How technological maturation, infection prevention priorities, procurement innovation, and sustainability commitments are reshaping adoption patterns and competitive positioning

The disposable endoscope sector is undergoing transformative shifts that extend beyond mere substitution of reusable devices. First, technological maturation has elevated the clinical credibility of disposable platforms through enhancements in optics, ergonomics, and device reliability, enabling use across a wider range of procedures. Second, supply chain innovation and manufacturing scale are progressively narrowing the price-performance differential relative to reusable systems, altering procurement calculus in favor of disposables for selected use cases. Third, heightened emphasis on infection prevention, catalyzed by high-profile contamination incidents and heightened public awareness, has sharpened attention on device-to-device cross-contamination risks and driven institutional demand for single-use alternatives.

Moreover, environmental sustainability considerations are driving parallel investments in product lifecycle management, recyclable materials, and device take-back programs, prompting a rethinking of single-use paradigms to incorporate circularity principles. Concurrently, payer scrutiny and contracting dynamics are encouraging bundled procurement approaches and outcome-based purchasing, which in turn incentivize manufacturers to demonstrate clear value propositions through clinical evidence, operational analytics, and cost-of-care modeling. As these shifts coalesce, the market is evolving from early-adopter experimentation to more standardized adoption pathways that prioritize demonstrable clinical and operational benefits.

Assessing the cascading effects of new tariff measures on supply chain economics, procurement strategies, and regional manufacturing decisions for disposable endoscopes

The introduction of new tariff policies in 2025 has exerted measurable pressure on the disposable endoscope supply chain by altering the relative economics of imported components, assembly, and finished-device shipments. Increased import duties on key components or finished products raise landed costs for buyers and create incentives for manufacturers to reassess geographic footprint, supplier contracts, and inventory strategies. In response, organizations are accelerating initiatives to diversify supplier bases, initiate nearshoring or regional manufacturing partnerships, and renegotiate long-term agreements to mitigate cost exposure.

These adjustments are prompting stakeholders to carry out more rigorous procurement scenario planning, including sensitivity analyses that consider tariff pass-through to end users, contract repricing triggers, and potential shifts in distribution models. At the same time, tariffs are motivating investments in localized manufacturing capabilities and contract manufacturing arrangements that prioritize supply continuity and tariff avoidance. While these moves can stabilize supply and control costs over the medium term, they require capital investment, supplier due diligence, and careful management of regulatory approvals across jurisdictions. Overall, tariffs are acting as a catalyst for supply chain resilience, regionalization strategies, and a reevaluation of total landed cost frameworks.

Granular segmentation insights revealing how product classes, device types, clinical applications, end-user characteristics, and distribution channels inform differentiated commercialization strategies

Distinct product segments and clinical applications are shaping both innovation priorities and adoption pathways in the disposable endoscope arena. Based on Product, the market differentiation across bronchoscopes, colonoscopes, and duodenoscopes reflects divergent technical requirements, sterility risk profiles, and clinical workflows, with each product class presenting unique performance thresholds and value metrics. Based on Type, the contrast between flexible endoscopes and rigid endoscopes influences design trade-offs, cost structures, and suitability for different procedural settings, as clinicians evaluate maneuverability, visualization, and tactile feedback. Based on Application, the application mix spanning arthroscopy, bronchoscopy, ENT endoscopy, gastrointestinal endoscopy, and urologic endoscopy demands tailored device specifications and clinical validation to meet the procedural complexity and imaging expectations of each specialty.

Furthermore, based on End-User, the needs of ambulatory surgical centers, diagnostic centers, and hospitals & clinics diverge significantly in terms of procedure volume, procurement cycles, and infection control protocols, which in turn affects preference for disposables versus reusables. Finally, based on Distribution Channel, direct sell models and online channels introduce different cost-to-serve dynamics, after-sales support expectations, and procurement behaviors. Taken together, segmentation-driven insights underscore the necessity for manufacturers to develop differentiated go-to-market strategies, clinical evidence plans, and pricing models that align with the clinical, operational, and economic priorities unique to each segment.

Key regional dynamics and differentiated adoption pathways across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement and commercialization approaches

Regional dynamics are shaping adoption velocities and competitive tactics across key markets, with different drivers and constraints influencing strategy. In the Americas, health systems are balancing infection control imperatives and throughput optimization against cost containment pressures, which is driving selective adoption in high-risk or high-turnover procedural areas; market activity is characterized by strategic procurement agreements, pilot programs, and increasing interest in lifecycle cost analyses. In the Europe, Middle East & Africa region, divergent regulatory frameworks, reimbursement structures, and healthcare delivery models create a heterogeneous landscape in which some markets adopt disposables rapidly to address contamination concerns, while others proceed more cautiously pending cost-effectiveness evidence and environmental policy alignment.

In the Asia-Pacific region, high procedural volumes, growing healthcare infrastructure investments, and localized manufacturing capabilities are accelerating uptake and fostering competitive entry by regional players. At the same time, clinicians and administrators across all regions are converging on common themes: the need for robust clinical evidence, transparent total cost comparisons, and practical sustainability measures that address end-of-life device management. Consequently, regional strategies that combine clinical partnerships, regulatory navigation, and tailored commercial models are essential to realize adoption while managing payer and public expectations.

Competitive dynamics and strategic behaviors among manufacturers, new entrants, and distribution partners that prioritize clinical evidence, scale, and integrated service offerings

Competitive dynamics in the disposable endoscope market are increasingly defined by the ability to integrate clinical credibility, manufacturing scale, and service-oriented commercial programs. Leading manufacturers are investing in clinical studies, usability testing, and post-market surveillance to substantiate safety and efficacy claims while also expanding production capacity and supply chain resilience to meet demand volatility. Partnerships between device developers and clinical institutions are becoming more common as a route to accelerate real-world evidence generation and clinician acceptance, and collaborations with contract manufacturers are enabling more flexible capacity management and cost optimization.

At the same time, new entrants and niche specialists are targeting specific procedural segments where disposable solutions can quickly demonstrate operational advantages, such as high-infection-risk environments or low-volume facilities that cannot justify reusable reprocessing infrastructure. Distribution strategies are evolving as well, with hybrid approaches that combine direct sales to large health systems and digital channels for smaller clinics, accompanied by service offerings like device take-back programs, training modules, and analytics dashboards to track usage and outcomes. Overall, companies that can deliver integrated solutions that address clinical performance, procurement simplicity, and environmental stewardship will be best positioned to capture sustained adoption.

Actionable strategic playbook for manufacturers and health systems to align clinical evidence, supply resilience, tailored commercial models, and sustainability commitments to drive adoption

Industry leaders should prioritize a multi-dimensional strategy that aligns product innovation with procurement realities, clinical validation, and sustainability commitments. First, invest in targeted clinical evidence programs that demonstrate procedural equivalence or superiority in defined use cases, focusing on patient safety outcomes and operational metrics such as turnover time and reprocessing burden. Second, optimize manufacturing and sourcing strategies to reduce exposure to tariff and supply chain disruptions by diversifying component suppliers, exploring regional manufacturing partnerships, and establishing flexible contract manufacturing arrangements. Third, develop differentiated commercial models that reflect the needs of ambulatory surgical centers, diagnostic centers, and hospitals & clinics, offering tailored pricing, service bundles, and training to accelerate uptake.

In addition, embed environmental mitigation measures into product design and lifecycle planning, including recyclable materials, take-back schemes, and transparent end-of-life reporting to address sustainability concerns and satisfy stakeholder scrutiny. Finally, invest in digital tools and analytics that provide procurement and clinical leaders with actionable insights on device utilization, cost per procedure drivers, and compliance, thereby strengthening the case for adoption while supporting continuous improvement in clinical workflows.

Rigorous mixed-methods research approach combining primary stakeholder interviews, secondary evidence synthesis, and iterative triangulation to ensure actionable insights and transparent limitations

The research methodology underpinning this analysis combines qualitative primary research with structured secondary investigation and iterative triangulation to ensure robustness and relevance. Primary inputs were synthesized from in-depth interviews with clinicians, procurement leaders, regulatory specialists, and supply chain executives, providing practical perspectives on clinical performance criteria, purchasing constraints, and operational priorities. Secondary research drew on regulatory publications, clinical literature, industry white papers, and publicly available policy communications to establish context on device standards, infection prevention guidance, and environmental policy trends.

Data synthesis employed cross-validation techniques to reconcile divergent stakeholder viewpoints and to surface consensus recommendations. Limitations of the methodology include the variable availability of published clinical outcomes across specific product classes and the evolving nature of trade and regulatory policies, which require ongoing monitoring. To mitigate these limitations, the study incorporates scenario analysis and sensitivity testing of strategic options, enabling decision-makers to assess potential pathways under differing regulatory, reimbursement, and supply chain conditions.

Concluding synthesis that balances infection prevention advantages, operational efficiencies, supply chain trade-offs, and sustainability responsibilities to guide strategic decision-making

Disposable endoscopes represent a consequential shift in procedural device strategy, offering tangible benefits in infection prevention and workflow efficiency while introducing new considerations around cost structure, sustainability, and supply chain design. As clinical capabilities of single-use platforms continue to improve, adoption will be shaped by the degree to which manufacturers can substantiate clinical value, resolve procurement and pricing complexities, and demonstrate credible environmental stewardship. Health systems and ambulatory providers must therefore navigate trade-offs between immediate infection control benefits and longer-term total cost and environmental obligations, making evidence-based pilot programs and phased rollouts prudent approaches.

Ultimately, the trajectory of disposable endoscope adoption will hinge on collaborative efforts among device manufacturers, clinical champions, procurement organizations, and policymakers to align incentives and to develop pragmatic frameworks for evaluation, procurement, and lifecycle management. Those stakeholders who proactively address clinician training, supply chain resilience, and sustainability are most likely to translate early commitments into measurable clinical and operational gains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Disposable Endoscopes Market, by Product

  • 8.1. Bronchoscopes
  • 8.2. Colonoscopes
  • 8.3. Duodenoscopes

9. Disposable Endoscopes Market, by Type

  • 9.1. Flexible Endoscopes
  • 9.2. Rigid Endoscopes

10. Disposable Endoscopes Market, by Application

  • 10.1. Arthroscopy
  • 10.2. Bronchoscopy
  • 10.3. ENT Endoscopy
  • 10.4. Gastrointestinal Endoscopy
  • 10.5. Urologic Endoscopy

11. Disposable Endoscopes Market, by End-User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals & Clinics

12. Disposable Endoscopes Market, by Distribution Channel

  • 12.1. Direct Sell
  • 12.2. Online

13. Disposable Endoscopes Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Disposable Endoscopes Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Disposable Endoscopes Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Disposable Endoscopes Market

17. China Disposable Endoscopes Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3NT Medical, Inc.
  • 18.6. Altek Corporation
  • 18.7. Ambu A/S
  • 18.8. B. Braun Melsungen AG
  • 18.9. BioVision Technologies, LLC by ATL Technology, LLC
  • 18.10. Boston Scientific Corporation
  • 18.11. Daichuan Medical (Shenzhen) Co., Ltd
  • 18.12. Dyne Medical Group
  • 18.13. EnlightenVue, Inc.
  • 18.14. Flexicare Medical Limited
  • 18.15. Fujifilm Holdings Corporation
  • 18.16. Hill-Rom Holdings, Inc.
  • 18.17. Integrated Endoscopy
  • 18.18. Intersurgical Ltd.
  • 18.19. IQ Endoscopes Limited
  • 18.20. J-Sol Medical Co., Ltd.
  • 18.21. Karl Storz SE & Co. KG
  • 18.22. NeoScope, Inc.
  • 18.23. Olympus Corporation
  • 18.24. OTU Medical Inc.
  • 18.25. Parburch Medical Developments Ltd
  • 18.26. PENTAX Medical
  • 18.27. Scivita Medical Technology Co., Ltd.
  • 18.28. STERIS Corporation
  • 18.29. Teleflex Incorporated
  • 18.30. The Cooper Companies, Inc.
  • 18.31. The Surgical Company
  • 18.32. Verathon Inc. by Roper Technologies, Inc.
  • 18.33. Zhejiang Geyi Medical Instrument Co., Ltd.
  • 18.34. Zsquare Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DISPOSABLE ENDOSCOPES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DISPOSABLE ENDOSCOPES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DUODENOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DUODENOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ENT ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ENT ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ENT ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY UROLOGIC ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY UROLOGIC ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY UROLOGIC ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIRECT SELL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIRECT SELL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIRECT SELL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 113. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 128. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 131. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 134. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 137. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)